Müllerian Agenesis (MRKH): USMLE High-Yield Review

MRKH syndrome: congenital absence of uterus and upper vagina in 46,XX females with normal ovaries. Presents with primary amenorrhea; confirm by imaging; screen kidneys.

Introduction

Müllerian agenesis, also known as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, is a congenital absence of the uterus and upper vagina in phenotypic females with normal ovarian function. Affected patients are typically 46,XX and display normal secondary sexual characteristics because their ovaries function normally. The most common presentation is primary amenorrhea in an adolescent with normal breast and pubic hair development. Diagnosis centers on documenting an absent uterus on pelvic imaging and assessing for associated renal and skeletal anomalies.

**Step 1 Focus:** Remember the embryologic origin: Müllerian (paramesonephric) ducts form the uterus, cervix, fallopian tubes, and upper two-thirds of the vagina.

**Step 2 CK Focus:** In an adolescent with primary amenorrhea and normal secondary sexual traits, a pelvic exam or ultrasound that shows no uterus with normal ovaries is diagnostic; evaluate the kidneys with renal ultrasound.

Pathophysiology

Müllerian agenesis results from failure of the Müllerian ducts to properly develop. These ducts normally give rise to the uterus, cervix, and the upper two-thirds of the vagina. When development fails, internal uterine structures and the upper vagina are absent, while the lower vagina is present.

Ovarian structure and function are preserved because ovaries arise from the germinal ridge rather than the Müllerian ducts. Normal ovarian estrogen production explains intact breast development and other secondary sexual characteristics. External genitalia appear normal because they are not derived from the Müllerian ducts.

A key embryologic contrast is with the Wolffian (mesonephric) ducts, which form the male internal genital tract. In MRKH, there is no disturbance in androgen production or action, so pubic and axillary hair are present. This intact androgen effect differentiates MRKH from conditions such as androgen insensitivity syndrome.

Clinical Presentation

Adolescents typically present with primary amenorrhea despite normal pubertal progression. Breast development is age-appropriate due to normal ovarian estrogen secretion. Pubic and axillary hair are present, reflecting normal androgen levels.

On examination, the vagina may be short or blind-ending because the upper portion is absent. The lower vagina is present, but overall vaginal length can be reduced. Associated renal and skeletal anomalies are common, such as unilateral renal agenesis and vertebral defects, so a focused review of systems and screening are important.

Key clinical features in MRKH include:

• Primary amenorrhea with normal secondary sexual characteristics.
• Normal external genitalia; short or blind-ending vagina on exam.
• Absent uterus on imaging with normal-appearing ovaries.
• Possible associated renal and skeletal anomalies.

Diagnostic Approach

Start with the clinical context: an adolescent with primary amenorrhea and normal breast and pubic hair development. This combination immediately raises suspicion for a structural cause rather than a primary endocrine failure. A careful pelvic exam can identify a short or blind-ending vagina and supports targeted imaging.

Pelvic ultrasound is an appropriate initial imaging modality to confirm absence of the uterus and to visualize normal ovaries. Finding normal ovaries alongside an absent uterus in a 46,XX patient establishes MRKH. Because associated anomalies are common, always perform a renal ultrasound to evaluate for urinary tract malformations.

Differential diagnosis should prioritize distinguishing MRKH from androgen insensitivity syndrome (AIS) and from obstructive lesions such as a transverse vaginal septum or an imperforate hymen. Clues favoring obstruction include cyclic pelvic pain and evidence of retained menstrual blood (hematocolpos), whereas MRKH lacks menses entirely due to the absent uterus. In AIS, pubic hair is absent or sparse due to defective androgen receptors, and patients have a 46,XY karyotype with undescended testes.

**Step 2 CK Focus:** For a patient with primary amenorrhea, normal breast development, and an absent uterus on pelvic imaging, the diagnosis is MRKH. After confirming uterine absence and normal ovaries, proceed with renal ultrasound screening.

Management & Prevention

Management is multidisciplinary, with attention to psychological support, sexual function, and reproductive counseling. First-line therapy to create a functional vaginal canal is non-surgical vaginal dilation. This approach is preferred and aims to achieve adequate length and function for sexual activity.

Surgical neovagina creation is reserved for refractory cases when dilation is insufficient or not feasible. Decisions are individualized and should be made with informed counseling. Because ovarian function is normal, oocytes are functional, and pregnancy is possible via assisted reproduction using a gestational surrogacy pathway.

Comprehensive care includes screening for associated renal and skeletal anomalies, given their frequency in MRKH. Ongoing psychological support is essential to address identity, sexual health, and reproductive planning. Counseling should clearly communicate the diagnosis, the rationale for dilation-first management, and the available assisted reproduction options such as in vitro fertilization (IVF) with a gestational carrier.

High-Yield Differentials & Pitfalls

The following table contrasts MRKH with key look-alike conditions that also present with primary amenorrhea and normal or near-normal secondary sexual characteristics.

| Condition | Karyotype | Uterus | Pubic Hair | Key Feature | |---|---|---|---|---| | Müllerian Agenesis (MRKH) | 46,XX | Absent | Present | Normal ovaries and estrogen; absent uterus and upper vagina | | Androgen Insensitivity Syndrome (AIS) | 46,XY | Absent | Absent/Sparse | Undescended testes; androgen receptor defect | | Transverse Vaginal Septum / Imperforate Hymen | 46,XX | Present | Present | Outflow obstruction; cyclic pain, hematocolpos |

High-yield pitfalls to avoid:

• Focusing only on uterine absence and missing the karyotype: MRKH is 46,XX, whereas AIS is 46,XY.
• Overlooking pubic hair patterns: present in MRKH due to intact androgen action; absent or sparse in AIS.
• Confusing MRKH with obstructive anomalies: obstruction retains menses and causes cyclic pain; MRKH has no menses because there is no uterus.
• Forgetting associated anomalies: renal ultrasound screening is part of the initial workup.

**Step 1 Focus:** Differentiate MRKH from AIS by noting that both lack a uterus, but MRKH occurs in 46,XX individuals with intact androgen response, while AIS affects 46,XY individuals with defective androgen receptors and sparse pubic hair.

Exam Vignette

A 15-year-old girl presents for evaluation of primary amenorrhea. She reports normal breast development since age 12 and has coarse pubic and axillary hair. She is not sexually active. Physical exam shows normal external female genitalia and a blind-ending vaginal pouch. Pelvic ultrasound reveals no identifiable uterus and normal-appearing ovaries. Renal ultrasound is ordered.

What is the most likely diagnosis?

• Müllerian agenesis (Mayer-Rokitansky-Küster-Hauser syndrome).

Brief reasoning:

• Primary amenorrhea with normal secondary sexual characteristics indicates normal ovarian estrogen production.
• Normal pubic hair supports intact androgen action, arguing against androgen insensitivity.
• Absent uterus with normal ovaries on imaging confirms MRKH.
• Renal ultrasound is appropriate because renal anomalies are common in MRKH.

Key Takeaways

• Müllerian agenesis (MRKH) is a congenital failure of Müllerian duct development causing absence of the uterus and upper vagina in 46,XX phenotypic females.
• Ovaries are normal because they arise from the germinal ridge; estrogen production preserves breast development and other secondary sexual traits.
• Typical presentation is primary amenorrhea in an adolescent with normal breasts and pubic hair; the vagina may be short or blind-ending.
• Diagnosis is made by pelvic exam and imaging showing no uterus and normal ovaries; always evaluate for renal anomalies with renal ultrasound.
• First-line management for creating a functional vaginal canal is non-surgical dilation; surgical neovagina is reserved for refractory cases.
• Fertility counseling should emphasize that oocytes are functional and pregnancy is possible via IVF with a gestational carrier.

Keep Learning

• Rehearse the embryologic map: which structures arise from Müllerian ducts versus Wolffian ducts, and how this explains the MRKH phenotype.
• Build a primary amenorrhea algorithm anchored on secondary sexual characteristics, uterine presence/absence, and the key differentials of MRKH, AIS, and outflow obstruction.
• Practice explaining management: why non-surgical dilation is first-line, when to consider surgical neovagina, and how assisted reproduction with a gestational carrier works for MRKH.
• Remember systems-based care: after confirming MRKH, screen for renal and skeletal anomalies and incorporate psychological support and sexual health counseling into the care plan.